Pancreatic Cancer Research

ResearcherUniversity Hospitals of ClevelandActive in the last 2 years

Akram S. Shalaby

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-8394-2963; OpenAlex author ID A5068626603. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Molecular Pathology of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17213549↗
  2. IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-1895↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yue Xue · 1 shared paper, 2025 · strength 0.42
  2. Luke Daniel Rothermel · 1 shared paper, 2024 · strength 0.18
  3. Jonathan J. Hue · 1 shared paper, 2024 · strength 0.18
  4. Ali Vaziri Gohar · 1 shared paper, 2024 · strength 0.18
  5. Mehrdad Zarei · 1 shared paper, 2024 · strength 0.18
  6. Omid Hajihassani · 1 shared paper, 2024 · strength 0.18
  7. Faith Nakazzi · 1 shared paper, 2024 · strength 0.18
  8. Jonathan Robert Brody · 1 shared paper, 2024 · strength 0.18
  9. Jordan Michael Winter · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.